Summary of opinion: Cresemba, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 13:41
Summary of opinion: Cresemba, 27/06/2024 Positive
Clinical investigation of recombinant and human plasma-derived factor IX products - Scientific guideline
Submitted by Anonymous (not verified) on 28 June 2024 - 13:40
Clinical investigation of recombinant and human plasma-derived factor IX products - Scientific guideline
Mandate, objectives and rules of procedure of the Scientific Advice Working Party (SAWP)
Submitted by Anonymous (not verified) on 28 June 2024 - 13:18
Mandate, objectives and rules of procedure of the Scientific Advice Working Party (SAWP)
Clinical Trial Information System (CTIS) - Sponsor handbook
Submitted by Anonymous (not verified) on 28 June 2024 - 13:13
Clinical Trial Information System (CTIS) - Sponsor handbook
Paediatric investigation plan (PIP) - Key elements guidance
Submitted by Anonymous (not verified) on 28 June 2024 - 12:59
Paediatric investigation plan (PIP) - Key elements guidance
CTIS newsflash - 28 June 2024
Submitted by Anonymous (not verified) on 28 June 2024 - 12:56
CTIS newsflash - 28 June 2024
Human medicines European public assessment report (EPAR): Neulasta, pegfilgrastim, Date of authorisation: 22/08/2002, Revision: 40, Status: Authorised
Submitted by Anonymous (not verified) on 28 June 2024 - 12:39
Human medicines European public assessment report (EPAR): Neulasta, pegfilgrastim, Date of authorisation: 22/08/2002, Revision: 40, Status: Authorised
Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorised
Submitted by Anonymous (not verified) on 28 June 2024 - 12:36
Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorised
Draft guideline on the conduct of efficacy studies for intramammary products for use in cattle
Submitted by Anonymous (not verified) on 28 June 2024 - 12:00
Draft guideline on the conduct of efficacy studies for intramammary products for use in cattle
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024
Submitted by Anonymous (not verified) on 28 June 2024 - 11:01
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024